<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yousefian-Jazi A</submitter><funding>KIST Grant</funding><funding>NINDS NIH HHS</funding><funding>National Research Foundation</funding><funding>NIH R01</funding><funding>Korea Dementia Research Project Grant</funding><pagination>16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11806887</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the loss of both upper and lower motor neurons, leading to progressive paralysis. Both genetic alterations and epigenetic modifications contribute to neuronal dysfunction in the pathogenesis of ALS. However, the mechanism behind genetic mutations in the non-coding region of genes that affect epigenetic modifications remains unclear.&lt;h4>Methods&lt;/h4>Convolutional neural network was used to identify an ALS-associated SNP located in the intronic region of MEF2C (rs304152), residing in a putative enhancer element. To examine the alteration of MEF2C transcription by the SNP, we generated HEK293T cells carrying the major or minor allele by CRISPR-Cas9. To verify the role of MEF2C-knockdow</pubmed_abstract><journal>Molecular neurodegeneration</journal><pubmed_title>Loss of MEF2C function by enhancer mutation leads to neuronal mitochondria dysfunction and motor deficits in mice.</pubmed_title><pmcid>PMC11806887</pmcid><funding_grant_id>2E30954</funding_grant_id><funding_grant_id>R01 NS109537</funding_grant_id><funding_grant_id>HU23C0217</funding_grant_id><funding_grant_id>2022R1A2C3013138</funding_grant_id><funding_grant_id>R01NS109537</funding_grant_id><pubmed_authors>Hwang H</pubmed_authors><pubmed_authors>Lee J</pubmed_authors><pubmed_authors>Lee K</pubmed_authors><pubmed_authors>Hyeon SJ</pubmed_authors><pubmed_authors>Ryu H</pubmed_authors><pubmed_authors>Nguyen PTT</pubmed_authors><pubmed_authors>Park U</pubmed_authors><pubmed_authors>Stein TD</pubmed_authors><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Choi SH</pubmed_authors><pubmed_authors>Yousefian-Jazi A</pubmed_authors><pubmed_authors>Lim G</pubmed_authors><pubmed_authors>Kim Y</pubmed_authors><pubmed_authors>Rhim H</pubmed_authors><pubmed_authors>Ryu HL</pubmed_authors><pubmed_authors>Chu J</pubmed_authors><pubmed_authors>Lim K</pubmed_authors><pubmed_authors>Kim MG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of MEF2C function by enhancer mutation leads to neuronal mitochondria dysfunction and motor deficits in mice.</name><description>&lt;h4>Background&lt;/h4>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the loss of both upper and lower motor neurons, leading to progressive paralysis. Both genetic alterations and epigenetic modifications contribute to neuronal dysfunction in the pathogenesis of ALS. However, the mechanism behind genetic mutations in the non-coding region of genes that affect epigenetic modifications remains unclear.&lt;h4>Methods&lt;/h4>Convolutional neural network was used to identify an ALS-associated SNP located in the intronic region of MEF2C (rs304152), residing in a putative enhancer element. To examine the alteration of MEF2C transcription by the SNP, we generated HEK293T cells carrying the major or minor allele by CRISPR-Cas9. To verify the role of MEF2C-knockdow</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-02T00:13:30.356Z</modification><creation>2025-04-04T13:11:10.636Z</creation></dates><accession>S-EPMC11806887</accession><cross_references><pubmed>39920775</pubmed><doi>10.1186/s13024-024-00792-y</doi></cross_references></HashMap>